Literature DB >> 26755567

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae.

Matthias I Gröschel1, Till F Omansen2, Wiel de Lange2, Tjip S van der Werf2, Mariëtte Lokate2, Erik Bathoorn2, Onno W Akkerman2, Ymkje Stienstra2.   

Abstract

Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diagnostic culture identified the venous access port as source, and upon surgical removal and antimicrobial therapy rapid clinical improvement was achieved. Increased awareness and knowledge on the prevalence of multi-resistant Enterobacteriaceae is needed, notably in TB centers, to provide a safe hospital environment to our patients. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26755567      PMCID: PMC4775883          DOI: 10.4269/ajtmh.15-0690

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals.

Authors:  Sibhghatulla Shaikh; Jamale Fatima; Shazi Shakil; Syed Mohd Danish Rizvi; Mohammad Amjad Kamal
Journal:  Saudi J Biol Sci       Date:  2014-05-26       Impact factor: 4.219

2.  Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density.

Authors:  P M C Huijbers; M de Kraker; E A M Graat; A H A M van Hoek; M G van Santen; M C M de Jong; E van Duijkeren; S C de Greeff
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

3.  Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis.

Authors:  J B Sarma; B Marshall; V Cleeve; D Tate; T Oswald; S Woolfrey
Journal:  J Hosp Infect       Date:  2015-06-09       Impact factor: 3.926

4.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

5.  Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.

Authors:  Dror Marchaim; Teena Chopra; Ashish Bhargava; Christopher Bogan; Sorabh Dhar; Kayoko Hayakawa; Jason M Pogue; Suchitha Bheemreddy; Christopher Blunden; Maryann Shango; Jessie Swan; Paul R Lephart; Federico Perez; Robert A Bonomo; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2012-06-11       Impact factor: 3.254

6.  Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.

Authors:  R Leistner; S Gürntke; C Sakellariou; L A Denkel; A Bloch; P Gastmeier; F Schwab
Journal:  Infection       Date:  2014-08-07       Impact factor: 3.553

7.  Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Authors:  Ana Elena Pérez-Cobas; María José Gosalbes; Anette Friedrichs; Henrik Knecht; Alejandro Artacho; Kathleen Eismann; Wolfgang Otto; David Rojo; Rafael Bargiela; Martin von Bergen; Sven C Neulinger; Carolin Däumer; Femke-Anouska Heinsen; Amparo Latorre; Coral Barbas; Jana Seifert; Vitor Martins dos Santos; Stephan J Ott; Manuel Ferrer; Andrés Moya
Journal:  Gut       Date:  2012-12-12       Impact factor: 23.059

8.  Antibiotic consumption and its influence on the resistance in Enterobacteriaceae.

Authors:  Miroslava Htoutou Sedláková; Karel Urbánek; Vladimíra Vojtová; Hana Suchánková; Peter Imwensi; Milan Kolář
Journal:  BMC Res Notes       Date:  2014-07-16

9.  Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.

Authors:  Dominique J Pepper; Kevin Rebe; Chelsea Morroni; Robert J Wilkinson; Graeme Meintjes
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

  9 in total
  1 in total

1.  Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.

Authors:  Sofanne J Ravensbergen; Christina Louka; Mariëtte Lokate; Erik Bathoorn; Spyros Pournaras; Tjip S van der Werf; Wiel C M de Lange; Ymkje Stienstra; Onno W Akkerman
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.